Enzymatic inhibitors, such as 3-Deazaneplanocin A (DZNep), indirectly inhibit EZH2 by increasing the activity of S-adenosyl-L-homocysteine hydrolase (SAH), leading to apoptosis in tumor cells (101). This evidence concerns the gene EZH2 and neoplasm.